万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603392 万泰生物

已收盘 11-18 15:00:00

{"stockData":{"symbol":"603392","market":"SH","secType":"STK","nameCN":"万泰生物","latestPrice":71,"timestamp":1731913200000,"preClose":72.16,"halted":0,"volume":3693113,"delay":0,"floatShares":1265000000,"shares":1265000000,"eps":-0.2325,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.16,"latestTime":"11-18 15:00:00","open":72.9,"high":72.96,"low":70.8,"amount":265000000,"amplitude":0.0299,"askPrice":71.02,"askSize":5,"bidPrice":71,"bidSize":62,"shortable":0,"etf":0,"ttmEps":-0.2325,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"adjPreClose":72.16,"symbolType":"stock","openAndCloseTimeList":[[1731893400000,1731900600000],[1731906000000,1731913200000]],"highLimit":79.38,"lowLimit":64.94,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1265122774,"pbRate":7.23,"roa":"--","roe":"2.12%","epsLYR":0.99,"committee":0.038462,"marketValue":89824000000,"floatMarketCap":89824000000,"peRate":-305.376342,"changeRate":-0.0161,"turnoverRate":0.0029,"status":1},"requestUrl":"/m/hq/s/603392","defaultTab":"news","newsList":[{"id":"2484629533","title":"A股公告精选 | 10连板大千生态(603955.SH)提示风险 万泰生物(603392.SH)九价HPV疫苗男性临床试验申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2484629533","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484629533?lang=zh_cn&edition=full","pubTime":"2024-11-18 20:07","pubTimestamp":1731931669,"startTime":"0","endTime":"0","summary":"10连板大千生态(603955.SH)：公司股价可能存在短期涨幅较大后下跌的风险。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20241118/20241118200819_84415.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241118/20241118200819_84415.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["399300","603955","BK0239","09633","BK1583","BK0145","BK0201","159982","BK1576","BK1589","159646","LU1981816686.USD","03347","BK1200","BK1141","BK0178","BK0277","603392"],"gpt_icon":0},{"id":"2484494116","title":"万泰生物获批男性九价HPV疫苗临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2484494116","media":"财中社","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484494116?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:35","pubTimestamp":1731922505,"startTime":"0","endTime":"0","summary":"财中社11月18日电万泰生物 发布关于公司九价HPV疫苗男性临床试验申请获得药物临床试验批准通知书的公告。公司全资子公司厦门万泰沧海生物技术有限公司近日收到国家药监局下发的通知书，批准开展九价人乳头瘤病毒疫苗针对男性人群的临床试验。九价HPV疫苗覆盖七种高危型和两种低危型，适用于预防由相关HPV型所致的多种癌症及其癌前病变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118174932a242aa77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118174932a242aa77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239","159646"],"gpt_icon":0},{"id":"2484649804","title":"万泰生物最新公告：九价HPV疫苗男性临床试验申请获药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2484649804","media":"证券之星","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484649804?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:29","pubTimestamp":1731922179,"startTime":"0","endTime":"0","summary":"万泰生物公告，公司全资子公司厦门万泰沧海生物技术有限公司收到国家药监局下发的《药物临床试验通知书》，同意公司九价人乳头瘤病毒疫苗（大肠埃希菌）开展针对男性人群适应症的临床试验。该疫苗覆盖HPV16/18/31/33/45/52/58七种高危型和HPV6/11两种低危型，适用于预防由HPV6/11/16/18/31/33/45/52/58型所致的生殖器疣、阴茎/会阴/肛周癌及其癌前病变、肛门癌及其癌前病变等适应症。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800024051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK1141","BK1589","09633","BK1583","LU1981816686.USD","BK1200","159646","603392","BK1576","BK0239"],"gpt_icon":0},{"id":"2484646034","title":"万泰生物(603392.SH)：九价HPV疫苗男性临床试验申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2484646034","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484646034?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:28","pubTimestamp":1731922118,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万泰生物(603392.SH)发布公告，公司全资子公司厦门万泰沧海生物技术有限公司收到国家药品监督管理局下发的《药物临床试验通知书》(通知书编号：2024LP02590)，同意公司九价人乳头瘤病毒疫苗(大肠埃希菌)(简称“九价HPV疫苗”)开展针对男性人群适应症的临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK1583","BK1576","159646","603392","09633","BK1589","LU1981816686.USD","BK1200","BK1141","BK0239"],"gpt_icon":0},{"id":"2484064656","title":"万泰生物：九价HPV疫苗男性临床试验申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2484064656","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484064656?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:27","pubTimestamp":1731922061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1141","BK1589","LU1981816686.USD","BK1583","BK1200","03347","603392","BK1576","159646","BK0239","09633"],"gpt_icon":0},{"id":"2484611586","title":"万泰生物11月18日主力资金流出1071万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484611586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484611586?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:19","pubTimestamp":1731914363,"startTime":"0","endTime":"0","summary":"11月18日, 万泰生物股价跌1.61%，报收71.00元，成交金额2.65亿元，换手率0.29%，振幅2.99%，量比0.81。万泰生物今日主力资金净流出1071万元，连续3日净流出，上一交易日主力净流出2351万元，今日环比减少54.44%。该股近5个交易日下跌5.33%，主力资金累计净流出974万元；近20日主力资金累计净流出3.83亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118153105abcba6bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118153105abcba6bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2483347946","title":"万泰生物11月15日现1笔大宗交易 成交金额6577.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483347946","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483347946?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:40","pubTimestamp":1731663600,"startTime":"0","endTime":"0","summary":"　　11月15日，万泰生物收跌2.16%，收盘价为72.16元，发生1笔大宗交易，合计成交量89.18万股，成交金额6577.03万元。　　进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为2.12亿元。该股近5个交易日累计下跌2.24%，主力资金合计净流出2183.95万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-11-15/doc-incwcvce9507305.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-15/doc-incwcvce9507305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603392","BK0239","BK1589","09633","BK1200","LU1981816686.USD"],"gpt_icon":0},{"id":"2483381344","title":"11月15日万泰生物现6577.03万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2483381344","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483381344?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:20","pubTimestamp":1731662441,"startTime":"0","endTime":"0","summary":"证券之星消息，11月15日万泰生物发生大宗交易，交易数据如下：大宗交易成交价格73.75元，相对当日收盘价溢价2.2%，成交89.18万股，成交金额6577.03万元，买方营业部为招商证券股份有限公司上海陆家嘴东路证券营业部，卖方营业部为招商证券股份有限公司上海陆家嘴东路证券营业部。近三个月该股共发生3笔大宗交易，合计成交2.89万手，溢价成交1笔。截至2024年11月15日收盘，万泰生物报收于72.16元，下跌2.16%，换手率0.27%，成交量3.46万手，成交额2.53亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500028151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603392","LU1981816686.USD","09633","BK1200","BK1589","BK0239"],"gpt_icon":0},{"id":"2482276517","title":"万泰生物11月11日收涨1.61% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2482276517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482276517?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:19","pubTimestamp":1731309579,"startTime":"0","endTime":"0","summary":"11月11日, 万泰生物股价涨1.61%，报收75.00元，成交金额3.75亿元，换手率0.40%，振幅3.06%，量比0.93。万泰生物今日主力资金净流出4006万元，上一交易日主力净流出4873万元，今日环比减少17.79%。该股近5个交易日上涨4.22%，主力资金累计净流出1.72亿元；近20日主力资金累计净流出4.54亿元，其中净流出天数为15日。净流出前三个股分别为长春高新、万泰生物、博雅生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111152747abb53301&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111152747abb53301&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2481848973","title":"万泰生物：公司严格按照相关规定履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2481848973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481848973?lang=zh_cn&edition=full","pubTime":"2024-11-07 18:00","pubTimestamp":1730973652,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物11月07日在投资者关系平台上答复投资者关心的问题。公司严格按照相关规定履行信息披露义务。今日国家药监局印发生物制品分段生产试点工作方案，请问对万泰HPV九价生产是否有帮助，谢谢万泰生物董秘：您好！公司九价HPV疫苗暂无分段生产的计划。公司九价HPV疫苗上市许可申请按计划推进中，公司严格按照相关规定履行信息披露义务，具体进展请关注公司相关的信息披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700029203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","BK1200","BK0239","LU1981816686.USD","603392","09633"],"gpt_icon":0},{"id":"2481547982","title":"万泰生物11月05日收涨1.42% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2481547982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481547982?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:19","pubTimestamp":1730791161,"startTime":"0","endTime":"0","summary":"11月05日, 万泰生物股价涨1.42%，报收72.98元，成交金额4.22亿元，换手率0.46%，振幅2.21%，量比1.27。万泰生物今日主力资金净流出5826万元，上一交易日主力净流出2287万元，今日环比增加154.74%。该股近5个交易日下跌0.64%，主力资金累计净流出1.25亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4.76亿元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105153721a2179c16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105153721a2179c16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2480696968","title":"疫苗上市公司为何业绩集体“失速”","url":"https://stock-news.laohu8.com/highlight/detail?id=2480696968","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480696968?lang=zh_cn&edition=full","pubTime":"2024-11-02 05:25","pubTimestamp":1730496327,"startTime":"0","endTime":"0","summary":"万泰生物的九价HPV疫苗上市申请已于8月26日获CDE受理，或将成为首个国产九价HPV疫苗。对于疫苗上市进展，万泰生物方面表示，九价疫苗上市进度受到广泛关注，公司正积极推动，达到披露标准会进行公告。三季报发布后，智飞生物公告佐剂四价流感疫苗获得国家药监局药物临床试验批准通知书。此前，四价流感病毒裂解疫苗价格已“跌破百元”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102060921ab951f78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102060921ab951f78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","159646","BK0239"],"gpt_icon":0},{"id":"2480888168","title":"万泰生物三季报扣非净利润下降97.55%，价格战后疫苗企业“一损俱损”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2480888168","media":"21财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480888168?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:45","pubTimestamp":1730468736,"startTime":"0","endTime":"0","summary":"扣非净利润更是降至4100万元，同比下降97.55%，接近亏损边缘。沃森生物2024年前三季度实现营收21.41亿元，同比下降32.19%；净利润2.56亿元，同比下降53.67%。营收、净利仍在下降万泰生物在2024年第三季度的营业收入为5.82亿元，同比下降27.72%；归属于上市公司股东的净利润为616.86万元，同比下降94.18%。万泰生物疫苗业务主要有戊肝疫苗、二价HPV疫苗和鼻喷新冠疫苗，其中，二价HPV疫苗是首个获批上市的国产HPV疫苗。万泰生物的业绩走势与HPV疫苗市场走势密不可分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101214539ab92cb10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101214539ab92cb10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","159646"],"gpt_icon":0},{"id":"2480072516","title":"11月1日万泰生物发生1笔大宗交易 成交金额5684.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480072516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480072516?lang=zh_cn&edition=full","pubTime":"2024-11-01 17:20","pubTimestamp":1730452825,"startTime":"0","endTime":"0","summary":"证券之星消息，11月1日万泰生物发生大宗交易，交易数据如下：大宗交易成交价格72.5元，成交78.4万股，成交金额5684.1万元，买方营业部为申万宏源证券有限公司盐城射阳兴阳广场证券营业部，卖方营业部为招商证券股份有限公司上海陆家嘴东路证券营业部。近三个月该股共发生2笔大宗交易，合计成交2.0万手。截至2024年11月1日收盘，万泰生物报收于72.5元，上涨1.57%，换手率0.4%，成交量5.07万手，成交额3.68亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100033738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603392","09633","BK0239","BK1589","LU1981816686.USD","BK1200"],"gpt_icon":0},{"id":"2478051611","title":"万泰生物：公司九价HPV疫苗上市许可申请按计划推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2478051611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478051611?lang=zh_cn&edition=full","pubTime":"2024-10-28 19:00","pubTimestamp":1730113242,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物10月28日在投资者关系平台上答复投资者关心的问题。公司九价HPV疫苗上市许可申请按计划推进中。公司将根据整体战略与市场需求，积极推动九价HPV疫苗男性群体的临床试验。公司严格按照相关规定履行信息披露义务，具体进展请关注公司相关的信息披露。经相关单位答复，该产品为万泰生物产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800026223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1981816686.USD","603392","09633","159646","BK1200","BK1589"],"gpt_icon":0},{"id":"2478492274","title":"三季报净利大降85%，万泰生物押宝九价HPV疫苗，能否重现高光时刻︱财报点评","url":"https://stock-news.laohu8.com/highlight/detail?id=2478492274","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478492274?lang=zh_cn&edition=full","pubTime":"2024-10-26 21:35","pubTimestamp":1729949701,"startTime":"0","endTime":"0","summary":"叠加新冠检测需求下降的影响，2023年以来万泰生物营收和盈利规模持续大幅回落，目前已基本回到了二价HPV疫苗上市前的水平。三季报显示，在盈利骤降超过80%的情况下，为加速九价HPV疫苗产业化，万泰生物在该项目上的投入仍较去年同期累计增加4000万元以上。可见万泰生物对其的厚望。与此同时，其他在研的国产九价HPV疫苗也是步步紧逼。今年7月，万泰生物宣布不再推进其子公司与GSK联合研发的HPV9-AS04候选疫苗项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026213601ab767a4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026213601ab767a4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159646","603392"],"gpt_icon":0},{"id":"2478949863","title":"万泰生物：P85-Ab鼻咽癌诊断试剂盒获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2478949863","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478949863?lang=zh_cn&edition=full","pubTime":"2024-10-26 15:42","pubTimestamp":1729928567,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4108","EB","09633","BK0239","LU1981816686.USD","BK4077","BK1589","603392","BK1200"],"gpt_icon":0},{"id":"2478600905","title":"万泰生物(603392.SH)子公司取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2478600905","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478600905?lang=zh_cn&edition=full","pubTime":"2024-10-25 18:58","pubTimestamp":1729853919,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万泰生物(603392.SH)发布公告，公司全资子公司厦门万泰凯瑞生物技术有限公司与厦门大学合作研发的EB病毒BNLF2b抗体检测试剂盒(磁微粒化学发光法)于近日收到国家药品监督管理局颁发的《中华人民共和国医疗器械注册证(体外诊断试剂)》。该产品用于体外定性检测人血清和血浆样本中EB病毒BNLF2b抗体。该产品可为EB相关的鼻咽癌诊断提供辅助参考信息。该产品获批上市，有助于公司进一步拓宽产品菜单丰富度，不断满足市场需求，是对公司现有检测产品的有效补充，将有利于提升公司在相关领域的竞争力，短期内对公司的经营业绩影响较小。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","09996","BK1589","BK1200","BK0239","BK1583","LU1981816686.USD","BK1222","09997","BK1574","BK1100","603392","09633"],"gpt_icon":0},{"id":"2478605766","title":"万泰生物：全资子公司取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2478605766","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478605766?lang=zh_cn&edition=full","pubTime":"2024-10-25 17:09","pubTimestamp":1729847384,"startTime":"0","endTime":"0","summary":"每经AI快讯，万泰生物 10月25日晚间发布公告称，北京万泰生物药业股份有限公司全资子公司厦门万泰凯瑞生物技术有限公司与厦门大学合作研发的EB病毒BNLF2b抗体检测试剂盒于近日收到国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》。2023年1至12月份，万泰生物的营业收入构成为：疫苗占比71.86%，体外诊断占比27.82%。截至发稿，万泰生物市值为961亿元。道达号“个股趋势”提醒：1. 近30日内无机构对万泰生物进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025171059ab732a08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025171059ab732a08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","159883","603392"],"gpt_icon":0},{"id":"2478760800","title":"万泰生物最新公告：全资子公司取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2478760800","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478760800?lang=zh_cn&edition=full","pubTime":"2024-10-25 17:00","pubTimestamp":1729846855,"startTime":"0","endTime":"0","summary":"万泰生物公告，全资子公司厦门万泰凯瑞生物技术有限公司与厦门大学合作研发的EB病毒BNLF2b抗体检测试剂盒(磁微粒化学发光法)近日收到国家药品监督管理局颁发的《中华人民共和国医疗器械注册证（体外诊断试剂）》。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500029083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1200","BK1589","BK1100","BK1583","09633","159883","LU1981816686.USD","BK1574","BK1222","09997","BK0239","09996","603392"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-04-29","address":"北京市昌平区科学园路31号","stockEarnings":[{"period":"1week","weight":-0.0533},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0869},{"period":"1year","weight":0.4678},{"period":"ytd","weight":-0.0505}],"companyName":"北京万泰生物药业股份有限公司","boardCode":"AI0027","perCapita":"38653股","boardName":"医药制造业","registeredCapital":"126512万元","compareEarnings":[{"period":"1week","weight":-0.0421},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.1595},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.0882},{"period":"ytd","weight":0.1173}],"survey":"　　北京万泰生物药业股份有限公司是从事体外诊断试剂、自动化检测设备、疫苗研发生产及销售的高新技术企业,其主要产品有疫苗、免疫诊断试剂、生化试剂、质控品、活性原料。公司获得国家企业技术中心、国家技术创新示范企业、国家地方联合工程实验室、国家知识产权优势企业、博士后科研工作站等95项省级及国家级荣誉称号；公司研发产品获得国家科学技术进步奖二等奖、国家技术发明奖二等奖、北京市科学技术一等奖、亚洲生物技术最佳创新奖及中国专利金奖等30项奖励。","serverTime":1731972417311,"listedPrice":8.75,"stockholders":"32730人(较上一季度减少13.21%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万泰生物,603392,万泰生物股票,万泰生物股票老虎,万泰生物股票老虎国际,万泰生物行情,万泰生物股票行情,万泰生物股价,万泰生物股市,万泰生物股票价格,万泰生物股票交易,万泰生物股票购买,万泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}